Amprion

About

Amprion Diagnostics is a biotechnology company focused on precision medicine for synucleinopathies and neurodegenerative diseases. It operates the first US CAP/CLIA-certified laboratory for the SAAmplify-αSYN test, which accurately detects misfolded alpha-synuclein in cerebrospinal fluid. This test has been validated with over 20,000 samples and more than 400 autopsy confirmations, making it a reliable tool for guiding treatment decisions. The company aims to enhance biopharma studies and clinical trials by providing early biomarker detection to improve patient outcomes. Amprion offers a range of services, including pathology-aligned development strategies for clinical trials, integrated diagnostic solutions, and research partnerships that generate insights into disease biology. Its primary customers are biopharma companies and clinicians, supporting drug development and diagnostic certainty in neurodegenerative disorders.